Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S MIDDLETON

Showing results (151-160 of 348) with videos related to

Pageof 35
Sort By:
Biochemical Society Transactions|August 1, 1990
Activation of human and murine T lymphocytes by cartilage proteoglycansJ A Goodacre, S Middleton, A Patterson, et al.
Obstetric Medicine|December 16, 2022
Delivery outcomes as a result of snoring as determined by standard sleep surveysA Robertson, A Makris, P Johnson, et al.
Transplantation Proceedings|September 29, 1999
Small intestine transplantation from cadaver donors: procurement procedureR Chavez-Cartaya, N V Jamieson, P J Friend, et al.
Emergency Medicine Journal : EMJ|December 24, 2008
Paediatric distal radial fracture manipulation: multicentre analysis of process timesL Mitchell, E Archer, S Middleton, et al.
Addiction (Abingdon, England)|March 15, 2011
The pharmacodynamic and pharmacokinetic profile of intranasal crushed buprenorphine and buprenorphine/naloxone tablets in opioid abusersLisa S Middleton, Paul A Nuzzo, Michelle R Lofwall, et al.
Journal of Medicinal Chemistry|November 15, 2002
Structure-activity relationships of 1-alkyl-5-(3,4-dichlorophenyl)- 5-[2-[(3-substituted)-1-azetidinyl]ethyl]-2-piperidones. 1. Selective antagonists of the neurokinin-2 receptorA Roderick MacKenzie, Allan P Marchington, Donald S Middleton, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 14, 2007
Cognitive impairment in patients with multiple sclerosis: association with the APOE gene and promoter polymorphismsB A Parmenter, D R Denney, S G Lynch, et al.
Synapse (New York, N.Y.)|December 6, 2006
Nornicotine inhibition of dopamine transporter function in striatum via nicotinic receptor activationLisa S Middleton, Peter A Crooks, Peter J Wedlund, et al.
Environmental Geochemistry and Health|June 20, 2016
Health risk assessment of potentially harmful elements and dietary minerals from vegetables irrigated with untreated wastewater, PakistanMunir H Zia, Michael J Watts, Abid Niaz, et al.
Pregnancy Hypertension|June 25, 2015
PP162. sFlt-1 controlled by CPAP in a pregnant patient with chronic hypertensionA L Daly, A Robertson, P Johnson, et al.
Pageof 35

Showing results (151-160 of 348) with videos related to

Sort By:
Pageof 35
Biochemical Society Transactions|August 1, 1990
Activation of human and murine T lymphocytes by cartilage proteoglycansJ A Goodacre, S Middleton, A Patterson, et al.
Obstetric Medicine|December 16, 2022
Delivery outcomes as a result of snoring as determined by standard sleep surveysA Robertson, A Makris, P Johnson, et al.
Transplantation Proceedings|September 29, 1999
Small intestine transplantation from cadaver donors: procurement procedureR Chavez-Cartaya, N V Jamieson, P J Friend, et al.
Emergency Medicine Journal : EMJ|December 24, 2008
Paediatric distal radial fracture manipulation: multicentre analysis of process timesL Mitchell, E Archer, S Middleton, et al.
Addiction (Abingdon, England)|March 15, 2011
The pharmacodynamic and pharmacokinetic profile of intranasal crushed buprenorphine and buprenorphine/naloxone tablets in opioid abusersLisa S Middleton, Paul A Nuzzo, Michelle R Lofwall, et al.
Journal of Medicinal Chemistry|November 15, 2002
Structure-activity relationships of 1-alkyl-5-(3,4-dichlorophenyl)- 5-[2-[(3-substituted)-1-azetidinyl]ethyl]-2-piperidones. 1. Selective antagonists of the neurokinin-2 receptorA Roderick MacKenzie, Allan P Marchington, Donald S Middleton, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 14, 2007
Cognitive impairment in patients with multiple sclerosis: association with the APOE gene and promoter polymorphismsB A Parmenter, D R Denney, S G Lynch, et al.
Synapse (New York, N.Y.)|December 6, 2006
Nornicotine inhibition of dopamine transporter function in striatum via nicotinic receptor activationLisa S Middleton, Peter A Crooks, Peter J Wedlund, et al.
Environmental Geochemistry and Health|June 20, 2016
Health risk assessment of potentially harmful elements and dietary minerals from vegetables irrigated with untreated wastewater, PakistanMunir H Zia, Michael J Watts, Abid Niaz, et al.
Pregnancy Hypertension|June 25, 2015
PP162. sFlt-1 controlled by CPAP in a pregnant patient with chronic hypertensionA L Daly, A Robertson, P Johnson, et al.
Pageof 35